DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 126 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $731 | +223.5% | 57,498 | +257.8% | 0.01% | +250.0% |
| Q2 2023 | $226 | -84.7% | 16,072 | -82.1% | 0.00% | -90.5% |
| Q4 2022 | $1,474 | -99.9% | 89,970 | +2.6% | 0.02% | +16.7% |
| Q3 2022 | $1,622,000 | +699.0% | 87,728 | +466.9% | 0.02% | +800.0% |
| Q2 2022 | $203,000 | -91.0% | 15,474 | -93.6% | 0.00% | -87.5% |
| Q1 2022 | $2,252,000 | +238.1% | 242,998 | +1138.0% | 0.02% | +300.0% |
| Q3 2021 | $666,000 | +206.9% | 19,628 | +414.5% | 0.00% | 0.0% |
| Q4 2020 | $217,000 | -55.6% | 3,815 | -73.5% | 0.00% | -82.6% |
| Q3 2019 | $489,000 | – | 14,415 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |